In this study, we followed the γ-H2AX foci formation and disappearance in PBMC collected prior to, during and post-RT treatment in NSCLC patients recruited for the GalliPET VQ-RT prospective clinical trial. Here, H2AX is linked to non-small cell lung carcinoma.